PICKERING GRANT — SEC Form 4 filings
SEC reporting owner CIK 1258693. 41 Form 4 filings on record with FilingPulse; latest filed 2026-09-09.
Transaction summary — filings shown
Covers all 41 filings on record, filed 2024-01-25 to 2026-09-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 112 legs across 25 filings — 362,038 shares, $28,474,635 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 70.
- Largest priced transaction: sale of 30,000 shares @ $79.03 ($2,370,900) in Vaxcyte, Inc., filed 2024-02-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Vaxcyte, Inc. (PCVX) | CHIEF EXECUTIVE OFFICER, Director | 37 | — | 112 legs · 362,038 sh · $28,474,635 | 66 |
| LeonaBio, Inc. (LONA) | Director | 4 | — | — | 4 |
Form 4 filings — PICKERING GRANT
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-09 | 4 | Vaxcyte, Inc. (PCVX) | Tax withholding (F): 17,056 @ $60.36 | EDGAR |
| 2026-09-02 | 4 | Vaxcyte, Inc. (PCVX) | Tax withholding (F): 2,862 @ $60.74 · Tax withholding (F): 3,427 @ $61.58 | EDGAR |
| 2026-07-28 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 16,198 @ $2.03 · Sale (S): 11,783 @ $55.52 · Sale (S): 4,415 @ $55.93 · Sale (S): 756 @ $55.52 · Sale (S): 244 @ $55.96 · Sale (S): 622 @ $55.54 · +2 more | EDGAR |
| 2026-06-26 | 4 | Vaxcyte, Inc. (PCVX) | Sale (S): 6,683 @ $54.27 · Sale (S): 9,137 @ $55.27 · Sale (S): 6,417 @ $56.12 · Sale (S): 312 @ $54.34 · Sale (S): 356 @ $55.23 · Sale (S): 332 @ $55.99 · +3 more | EDGAR |
| 2026-06-24 | 4 | LeonaBio, Inc. (LONA) | Grant/award (A): 28,000 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 225 @ $1.79 · Sale (S): 225 @ $52.51 · Sale (S): 22,236 @ $52.50 · Sale (S): 1,000 @ $52.50 · Sale (S): 1,000 @ $52.50 · Option exercise (M): 225 (derivative) @ $0 | EDGAR |
| 2026-04-13 | 4 | LeonaBio, Inc. (LONA) | Grant/award (A): 28,000 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Vaxcyte, Inc. (PCVX) | Tax withholding (F): 3,685 @ $59.32 | EDGAR |
| 2026-03-02 | 4 | Vaxcyte, Inc. (PCVX) | Grant/award (A): 105,110 @ $0 · Tax withholding (F): 2,863 @ $61.98 · Tax withholding (F): 2,531 @ $61.98 · Grant/award (A): 175,698 (derivative) @ $0 | EDGAR |
| 2026-01-16 | 4 | Vaxcyte, Inc. (PCVX) | Gift (G): 100,000 @ $0 | EDGAR |
| 2025-09-10 | 4 | Vaxcyte, Inc. (PCVX) | Tax withholding (F): 7,356 @ $32.41 | EDGAR |
| 2025-09-04 | 4 | Vaxcyte, Inc. (PCVX) | Tax withholding (F): 2,857 @ $31.56 · Tax withholding (F): 4,563 @ $31.56 · Tax withholding (F): 3,420 @ $31.56 | EDGAR |
| 2025-06-03 | 4 | Athira Pharma, Inc. (ATHA) | Grant/award (A): 20,900 (derivative) @ $0 | EDGAR |
| 2025-04-07 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 15,781 @ $5.35 · Option exercise (M): 4,752 @ $20.93 · Option exercise (M): 15,781 (derivative) @ $0 · Option exercise (M): 4,752 (derivative) @ $0 | EDGAR |
| 2025-03-03 | 4 | Vaxcyte, Inc. (PCVX) | Grant/award (A): 57,938 @ $0 · Tax withholding (F): 2,013 @ $73.02 · Tax withholding (F): 7,984 @ $72.10 · Grant/award (A): 193,431 (derivative) @ $0 | EDGAR |
| 2024-12-10 | 4 | Vaxcyte, Inc. (PCVX) | Sale (S): 961 @ $92.06 · Sale (S): 222 @ $93.10 · Sale (S): 1,029 @ $92.03 · Sale (S): 154 @ $93.60 | EDGAR |
| 2024-12-03 | 4 | Vaxcyte, Inc. (PCVX) | Sale (S): 11,349 @ $92.06 · Sale (S): 1,409 @ $93.06 · Sale (S): 2,242 @ $94.06 | EDGAR |
| 2024-11-19 | 4 | Vaxcyte, Inc. (PCVX) | Gift (G): 710 @ $0 | EDGAR |
| 2024-11-08 | 4 | Vaxcyte, Inc. (PCVX) | Sale (S): 227 @ $102.68 · Sale (S): 463 @ $103.43 · Sale (S): 377 @ $104.71 · Sale (S): 116 @ $105.50 · Sale (S): 281 @ $102.64 · Sale (S): 363 @ $103.36 · +10 more | EDGAR |
| 2024-11-04 | 4 | Vaxcyte, Inc. (PCVX) | Sale (S): 9,955 @ $106.35 · Sale (S): 3,312 @ $107.34 · Sale (S): 1,733 @ $108.50 | EDGAR |
| 2024-10-08 | 4 | Vaxcyte, Inc. (PCVX) | Sale (S): 310 @ $107.27 · Sale (S): 887 @ $108.72 · Sale (S): 2,113 @ $109.58 · Sale (S): 239 @ $110.35 · Sale (S): 356 @ $107.50 · Sale (S): 807 @ $108.75 · +2 more | EDGAR |
| 2024-10-03 | 4 | Vaxcyte, Inc. (PCVX) | Sale (S): 3,624 @ $113.38 · Sale (S): 7,088 @ $114.27 · Sale (S): 4,288 @ $114.98 · Option exercise (M): 20,000 @ $5.35 · Sale (S): 4,305 @ $113.35 · Sale (S): 9,429 @ $114.20 · +7 more | EDGAR |
| 2024-09-05 | 4 | Vaxcyte, Inc. (PCVX) | Tax withholding (F): 13,669 @ $110.15 | EDGAR |
| 2024-08-26 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 15,000 @ $2.03 · Sale (S): 6,686 @ $78.65 · Sale (S): 8,314 @ $79.25 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2024-08-05 | 4 | Vaxcyte, Inc. (PCVX) | Sale (S): 1,308 @ $78.80 · Sale (S): 1,308 @ $78.78 | EDGAR |
| 2024-07-24 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 15,000 @ $2.03 · Sale (S): 5,718 @ $83.83 · Sale (S): 9,282 @ $84.53 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | Vaxcyte, Inc. (PCVX) | Sale (S): 674 @ $75.84 · Sale (S): 634 @ $76.86 · Sale (S): 751 @ $75.92 · Sale (S): 557 @ $76.89 | EDGAR |
| 2024-06-25 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 15,000 @ $2.03 · Sale (S): 10,341 @ $75.39 · Sale (S): 4,471 @ $76.17 · Sale (S): 188 @ $76.80 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Vaxcyte, Inc. (PCVX) | Sale (S): 705 @ $71.44 · Sale (S): 486 @ $72.66 · Sale (S): 117 @ $73.46 · Sale (S): 757 @ $71.43 · Sale (S): 327 @ $72.55 · Sale (S): 224 @ $73.43 | EDGAR |
| 2024-05-28 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 15,000 @ $2.03 · Sale (S): 6,211 @ $68.84 · Sale (S): 8,789 @ $69.84 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2024-05-24 | 4 | Athira Pharma, Inc. (ATHA) | Grant/award (A): 20,900 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | Vaxcyte, Inc. (PCVX) | Sale (S): 728 @ $61.25 · Sale (S): 508 @ $62.01 · Sale (S): 72 @ $63.87 · Sale (S): 680 @ $61.28 · Sale (S): 582 @ $62.07 · Sale (S): 46 @ $63.84 | EDGAR |
| 2024-04-25 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 15,000 @ $1.79 · Sale (S): 15,000 @ $61.92 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | Vaxcyte, Inc. (PCVX) | Sale (S): 984 @ $66.52 · Sale (S): 324 @ $67.27 · Sale (S): 890 @ $66.45 · Sale (S): 415 @ $67.24 · Sale (S): 3 @ $68.10 | EDGAR |
| 2024-03-27 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 15,000 @ $1.79 · Sale (S): 13,450 @ $66.87 · Sale (S): 1,550 @ $67.50 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2024-03-13 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 65,000 @ $2.03 · Option exercise (M): 65,000 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | Vaxcyte, Inc. (PCVX) | Grant/award (A): 45,000 @ $0 · Sale (S): 506 @ $73.04 · Sale (S): 439 @ $73.54 · Sale (S): 363 @ $74.69 · Sale (S): 366 @ $72.97 · Sale (S): 591 @ $73.59 · +3 more | EDGAR |
| 2024-02-27 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 15,000 @ $1.79 · Sale (S): 2,356 @ $75.15 · Sale (S): 6,980 @ $75.96 · Sale (S): 5,545 @ $76.95 · Sale (S): 119 @ $77.56 · Option exercise (M): 30,000 @ $1.79 · +3 more | EDGAR |
| 2024-02-05 | 4 | Vaxcyte, Inc. (PCVX) | Sale (S): 119 @ $71.93 · Sale (S): 491 @ $73.25 · Sale (S): 443 @ $74.37 · Sale (S): 255 @ $75.47 · Sale (S): 134 @ $71.93 · Sale (S): 655 @ $73.34 · +2 more | EDGAR |
| 2024-01-31 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 30,000 @ $1.79 · Sale (S): 30,000 @ $66.03 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2024-01-25 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 3,000 @ $0.04 · Option exercise (M): 12,000 @ $1.79 · Sale (S): 2,938 @ $63.22 · Sale (S): 10,023 @ $63.95 · Sale (S): 2,039 @ $64.78 · Option exercise (M): 3,000 (derivative) @ $0 · +1 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1258693 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →